Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
Leukemia & Lymphoma|May 7, 2010
Autologous transplant of follicular lymphoma in the era of rituximabMathias Witzens-Harig, Peter DregerOncology Research and Treatment|October 25, 2017
Cellular Immunotherapy in B-Cell MalignancyMark-Alexander Schwarzbich, Mathias Witzens-HarigRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
Acalabrutinib, A Second-Generation Bruton's Tyrosine Kinase InhibitorKatharina Kriegsmann, Mark Kriegsmann, Mathias Witzens-HarigRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
IbrutinibAndriani Charalambous, Mark-Alexander Schwarzbich, Mathias Witzens-HarigExpert Opinion on Pharmacotherapy|February 14, 2012
Update on immunomodulatory drugs (IMiDs) in hematologic and solid malignanciesSonia Vallet, Mathias Witzens-Harig, Dirk Jaeger, et al.BMC Cancer|March 1, 2011
Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trialMathias Witzens-Harig, Manfred Hensel, Michael Unterhalt, et al.Cancer|June 28, 2012
Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patientsAndreas Heilgeist, Fabienne McClanahan, Anthony D Ho, et al.BMC Cancer|June 27, 2013
A phase I/II trial to evaluate the safety, feasibility and activity of salvage therapy consisting of the mTOR inhibitor Temsirolimus added to standard therapy of Rituximab and DHAP for the treatment of patients with relapsed or refractory diffuse large cell B-Cell lymphoma - the STORM trialMathias Witzens-Harig, Marie Luise Memmer, Martin Dreyling, et al.Annals of Hematology|August 19, 2011
Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factorsChristian Johannes Schmitt, Sascha Dietrich, Antony Dick Ho, et al.Acta Ophthalmologica|September 29, 2007
Intravitreal autologous bone marrow-derived mononuclear cell transplantation: a feasibility reportJost B Jonas, Mathias Witzens-Harig, Lubomir Arseniev, et al.Pageof 8